本港即将踏入秋季，哮喘病容易发作，但要小心使用短效气管舒张剂（SABA）。香港大学研究发现，近6成哮喘患者每年需使用3支或以上SABA，属过度依赖，增加入院及死亡风险。香港哮喘会建议，哮喘患者要跟从医护人员指示用药，确保使用吸入器的方法正确，并使用哮 ...

Both short-acting ß2-agonists (SABAs) and long-acting ß2-agonists (LABAs) play important—but different—roles in asthma ...

Seretide/Advair (fluticasone propionate + salmeterol; GlaxoSmithKline) and Symbicort (budesonide + formoterol fumarate dihydrate; AstraZeneca), which are ICS–LABA combinations, are other popular ...

Asthma affects approximately 262 million people globally, with the number of asthma incidents having increased by around 15% ...

There are many types of asthma inhalers that differ in three key ways: Whether they are used for quick relief or long-term ...

Industrial control system (ICS) cybersecurity can be intimidating. The stakes are high, and the technology is sophisticated. Ask any industrial cybersecurity expert about it, and you are likely to ...

Formoterol Fumarate: Following inhaled administration ... Inform patients that long-term use of ICS may increase the risk of some eye problems (cataracts or glaucoma); consider regular eye ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

COPD: Chronic obstructive pulmonary disease; EIB: Exercise-induced bronchoconstriction; IβA: Inhaled β 2-agonist; ICS: Inhaled corticosteroid. Globally, the prevalence of asthma continues to ...

LABA as monotherapy (without ICS) for asthma can increase risk of ... not use another medicine containing a LABA (eg, salmeterol, formoterol fumarate, arformoterol tartrate, indacaterol) for ...

The global asthma treatment market size was valued at USD 27.51 billion in 2023 and is expected to reach around USD 35.93 billion by 2034. It is growing at a CAGR of 2.42% from 2024 and 2034. The ...